MARK4 and central nervous system cancer: AS of ANXA7, MARK4, MAX, USP5, WWOX, BIN, RON, and CCND1 were reported to affect critical biological functions of glioma, resulting in altered prognosis [13–15]; however, a systematic analysis of glioma splicing profiles has not been performed.